Study Title
PREDICT: Assessment of the Utility of Family-based (Trio) Whole-genome Sequencing for Cancer Predisposition Testing in Sequential Newly Diagnosed Paediatric and Adolescent Cancer Patients
Protocol ID
PREDICT
Condition/s
Neoplastic Syndromes, Hereditary
Cancer
Genetic Predisposition to Disease
Cancer
Genetic Predisposition to Disease
Diagnosis Stage
Newly diagnosed
Location
NSW
Sponsor
Sydney Children's Hospitals Network
Collaborators
Children's Cancer Institute Australia
Links
Trial Status
Open
Sites
Sydney Children's Hospital
The Children's Hospital at Westmead
John Hunter Children's Hospital
The Children's Hospital at Westmead
John Hunter Children's Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
up to 21 years
International registry ID's
NCT04903782
| Study Title | PREDICT: Assessment of the Utility of Family-based (Trio) Whole-genome Sequencing for Cancer Predisposition Testing in Sequential Newly Diagnosed Paediatric and Adolescent Cancer Patients |
|---|---|
| Protocol ID | PREDICT |
| Disease (Sub Disease) | Neoplastic Syndromes, Hereditary Cancer Genetic Predisposition to Disease |
| Diagnosis Stage | Newly diagnosed |
| Location | NSW |
| Sponsor | Sydney Children's Hospitals Network |
| Collaborators | Children's Cancer Institute Australia |
| Links | https://clinicaltrials.gov/ct2/show/NCT04903782 |
| Trial Status | Open |
| Trial Open Date | 08/03/2021 |
| Sites | Sydney Children's Hospital / The Children's Hospital at Westmead/ John Hunter Children's Hospital |
| Study Type | Observational |
| Phase | Not applicable |
| Age Eligibility | up to 21 years |
| International registry ID's | NCT04903782 |